Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Harvard Business School
AstraZeneca
McKinsey
McKesson

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Litigation Details for WATSON LABORATORIES, INC. v. SEBELIUS (D.C. 2012)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

WATSON LABORATORIES, INC. v. SEBELIUS (D.C. 2012)

Docket   Start Trial Date Filed 2012-08-15
Court District Court, District of Columbia Date Terminated
Cause 05:702 Administrative Procedure Act Assigned To Amy Berman Jackson
Jury Demand None Referred To
Parties KATHLEEN SEBELIUS; MARGARET A. HAMBURG; UNITED STATES FOOD AND DRUG ADMINISTRATION; WATSON LABORATORIES, INC.
Patents 5,965,584; 6,150,383; 6,150,384; 6,166,042; 6,166,043; 6,172,090; 6,211,205; 6,271,243; 6,303,640; 6,329,404
Attorneys Aaron J. Feigenbaum; Chad A Landmon; Drake S. Cutini; Margaret L. Woodland; Mark D. Alexander; Nicholas E.O. Gaglio
Firms Axinn Veltrop Harkrider LLP; Axinn, Veltrop & Harkrider LLP; DEPARTMENT OF JUSTICE, Consumer Protection Branch; Margaret L. Woodland
Link to Docket External link to docket
Small Molecule Drugs cited in WATSON LABORATORIES, INC. v. SEBELIUS
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for WATSON LABORATORIES, INC. v. SEBELIUS (D.C. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-08-15 1 U.S. Patent Nos. 5,965,584 and 6,329,404) (collectively, the “Composition Patents”) and patents relating…name drug manufacturer should submit patent information – the patent’s number and its expiration date –…manufacturer has not filed patent information with FDA; or, for each patent listed in the Orange Book …seeking approval, (ii) that the patent has expired; (iii) that the patent expires on a date before which… Takeda is the holder of the patents for pioglitazone, including patents relating to the pharmaceutical External link to document
2012-10-22 53 infringement of U.S. Patent Nos. 5,965,584 and 6,329,404 – the drug composition/use patents. A.R. at 30; see…infringement of U.S. Patent Nos. 5,965,584 and 6,329,404 – the drug composition/use patents. x 12….S. Patent Nos. 5,965,584 and 6,329,404. Id. 8 …03 3/7/12 Drug 5,965,584 IV … 7/15/03 Drug 5,965,584 IV/viii External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Baxter
Medtronic
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.